CO2017004787A2 - Formulación de polvo seco - Google Patents
Formulación de polvo secoInfo
- Publication number
- CO2017004787A2 CO2017004787A2 CONC2017/0004787A CO2017004787A CO2017004787A2 CO 2017004787 A2 CO2017004787 A2 CO 2017004787A2 CO 2017004787 A CO2017004787 A CO 2017004787A CO 2017004787 A2 CO2017004787 A2 CO 2017004787A2
- Authority
- CO
- Colombia
- Prior art keywords
- dry powder
- powder formulation
- inhaler
- heating
- wrapper
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Esta invención proporciona un proceso para preparar una formulación farmacéutica de polvo seco inhalable que comprende la etapa de calentar una envoltura sellada que 5 contiene un desecante y un inhalador o una cápsula, el inhalador o cápsula que contiene, además, una formulación de polvo seco que comprende un ingrediente farmacéutico activo inhalable y un portador, en el que la envoltura forma una barrera a la entrada de humedad y en donde el calentamiento de 10 la envoltura sellada y su contenido se lleva a cabo a una temperatura de 30-50 °C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462064690P | 2014-10-16 | 2014-10-16 | |
PCT/US2015/055919 WO2016061448A1 (en) | 2014-10-16 | 2015-10-16 | Dry powder formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2017004787A2 true CO2017004787A2 (es) | 2017-09-20 |
Family
ID=54427855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2017/0004787A CO2017004787A2 (es) | 2014-10-16 | 2017-05-12 | Formulación de polvo seco |
Country Status (15)
Country | Link |
---|---|
US (1) | US9980904B2 (es) |
EP (1) | EP3206668A1 (es) |
JP (1) | JP6653324B2 (es) |
KR (1) | KR20170068571A (es) |
CN (1) | CN107106514A (es) |
AR (1) | AR102305A1 (es) |
AU (1) | AU2015331915A1 (es) |
BR (1) | BR112017007587A2 (es) |
CA (1) | CA2963146A1 (es) |
CO (1) | CO2017004787A2 (es) |
EA (1) | EA201790833A1 (es) |
IL (1) | IL251665A0 (es) |
MX (1) | MX2017004764A (es) |
PE (1) | PE20170690A1 (es) |
WO (1) | WO2016061448A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170070151A (ko) * | 2014-10-16 | 2017-06-21 | 테바 브랜디드 파마슈티컬 프로덕츠 알앤디, 인코포레이티드 | 흡입형 제제 |
EP3833964B1 (en) | 2018-08-07 | 2023-07-26 | Norton (Waterford) Limited | Application of raman spectroscopy for the manufacture of inhalation powders |
JP2023539073A (ja) | 2020-08-14 | 2023-09-13 | ノートン (ウォーターフォード) リミテッド | プロピオン酸フルチカゾンと硫酸アルブテロールの吸入製剤 |
GB202012742D0 (en) * | 2020-08-14 | 2020-09-30 | Norton Waterford Ltd | An inhalable medicament |
US20240050382A1 (en) * | 2022-08-11 | 2024-02-15 | De Motu Cordis Pty Ltd | Inhalable Epinephrine Formulation |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9027234D0 (en) | 1990-12-15 | 1991-02-06 | Harris Pharma Ltd | An inhalation device |
US6258341B1 (en) | 1995-04-14 | 2001-07-10 | Inhale Therapeutic Systems, Inc. | Stable glassy state powder formulations |
SE0303570L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
PL1718353T3 (pl) | 2004-02-24 | 2020-06-01 | Microdose Therapeutx, Inc. | Urządzenie do dostarczania leku na bazie strugi syntetycznej |
GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
US8196576B2 (en) | 2007-02-28 | 2012-06-12 | Microdose Therapeutx, Inc. | Inhaler |
PE20090907A1 (es) * | 2007-07-21 | 2009-08-05 | Boehringer Ingelheim Int | Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente |
GB0919465D0 (en) | 2009-11-06 | 2009-12-23 | Norton Healthcare Ltd | Airflow adaptor for a breath-actuated dry powder inhaler |
-
2015
- 2015-10-16 EA EA201790833A patent/EA201790833A1/ru unknown
- 2015-10-16 MX MX2017004764A patent/MX2017004764A/es unknown
- 2015-10-16 KR KR1020177013067A patent/KR20170068571A/ko unknown
- 2015-10-16 AU AU2015331915A patent/AU2015331915A1/en not_active Abandoned
- 2015-10-16 CN CN201580055454.1A patent/CN107106514A/zh active Pending
- 2015-10-16 BR BR112017007587A patent/BR112017007587A2/pt not_active Application Discontinuation
- 2015-10-16 PE PE2017000539A patent/PE20170690A1/es not_active Application Discontinuation
- 2015-10-16 WO PCT/US2015/055919 patent/WO2016061448A1/en active Application Filing
- 2015-10-16 CA CA2963146A patent/CA2963146A1/en not_active Abandoned
- 2015-10-16 EP EP15790737.9A patent/EP3206668A1/en not_active Withdrawn
- 2015-10-16 US US15/519,447 patent/US9980904B2/en not_active Expired - Fee Related
- 2015-10-16 JP JP2017519635A patent/JP6653324B2/ja not_active Expired - Fee Related
- 2015-10-16 AR ARP150103366A patent/AR102305A1/es unknown
-
2017
- 2017-04-09 IL IL251665A patent/IL251665A0/en unknown
- 2017-05-12 CO CONC2017/0004787A patent/CO2017004787A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
EA201790833A1 (ru) | 2017-09-29 |
KR20170068571A (ko) | 2017-06-19 |
AR102305A1 (es) | 2017-02-15 |
CA2963146A1 (en) | 2016-04-21 |
CN107106514A (zh) | 2017-08-29 |
PE20170690A1 (es) | 2017-05-25 |
JP2017530995A (ja) | 2017-10-19 |
WO2016061448A1 (en) | 2016-04-21 |
US9980904B2 (en) | 2018-05-29 |
US20170239177A1 (en) | 2017-08-24 |
MX2017004764A (es) | 2017-07-27 |
EP3206668A1 (en) | 2017-08-23 |
AU2015331915A1 (en) | 2017-05-25 |
IL251665A0 (en) | 2017-06-29 |
JP6653324B2 (ja) | 2020-02-26 |
BR112017007587A2 (pt) | 2018-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017004787A2 (es) | Formulación de polvo seco | |
IL264413B (en) | Preparations containing fibers obtained electrohydrodynamically for delivering specific doses of active substance to the skin or mucous membrane | |
MX2018015699A (es) | Formulaciones de cannabinoide. | |
IL254353B (en) | A vaporizing capsule for the vaporization of an active ingredient | |
PH12016500547A1 (en) | Aerosol-generating system comprising a cylindrical polymeric capsule | |
EA201600100A1 (ru) | Защищенная от применения не по назначению лекарственная форма, содержащая этиленвинилацетатный полимер | |
HRP20220075T1 (hr) | Tekuća formulacija koja sadrži nikotin za aerosolnu primjenu | |
CL2013000293A1 (es) | Una formulacion en polvo seco inhalable que comprende como ingrediente activo particulas micronizadas de un compuesto inhibidor de fosfodiesterasa-4, como enantiomero (-) y particulas de un vehiculo; inhalador de polvo seco y envase que comprende a la formulacion, util para la prevencion y/o el tratamiento del asma y epoc. | |
BR112018011496A2 (pt) | sistema para distribuição de nicotina em pó | |
ES2969701T3 (es) | Derivado de N2,N4-difenilpirimidin-2,4-diamina, método de preparación del mismo y composición farmacéutica que lo contiene como principio activo para la prevención o el tratamiento del cáncer | |
CY1124490T1 (el) | Μια διεργασια για την παρασκευη ενος σκευασματος ξηρης σκονης που περιλαμβανει ενα αντιχολινεργικο, ενα κορτικοστεροειδες και ενα βητα-αδρενεργικο | |
DK3518892T3 (da) | Farmaceutisk formulering, der indeholder en insulinforbindelse | |
CL2016002560A1 (es) | Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación. | |
WO2013104892A8 (en) | Application of high dose compounds via inhalation | |
EP3375787A4 (en) | Peptide thiourea derivative, radioisotope labeled compound containing same, and pharmaceutical composition containing same as active ingredient for treating or diagnosing prostate cancer | |
EA201700019A1 (ru) | Высокочистый оритаванцин и способ его получения | |
CL2019000563S1 (es) | Envase y dispendio de medicamentos. (divisional solicitud 201800718) | |
GT201600267A (es) | Sulfentrazona de liberación controlada para proteger plantas | |
ZA201701820B (en) | Biocide and/or phytosanitary formulation for aerosol use, made of active biodegradable non-residual substances | |
GR1008818B (el) | Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα εχινοκανδινης και μεθοδος παρασκευης αυτου | |
IN2014DE00111A (es) | ||
TR201716207A2 (tr) | Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar. | |
CO2017004789A2 (es) | Formulación inhalable | |
ES1210064Y (es) | Cápsula monodosis para biberón | |
TR201714725A1 (tr) | Beta-2 agoni̇sti̇ ve anti̇koli̇nerji̇k i̇çeren kuru toz formülasyonu |